This was almost a year ago. I wonder how it turned out:
Scientists will trial a new longevity drug in the UK next year that they say could increase the life expectancy of some people to up to 120 years of age.
Researchers are developing a treatment that could significantly increase a person’s healthy lifespan and, in turn, their longevity, by boosting their immune systems. This has been made possible after they found a way to slow down – and potentially even prevent – the natural ageing of T cells, a key part of our immune defences.
Professor Lanna has set up a London-based company called SentCell to develop the vaccine, which he says will be trialled in humans in 2023.
Asked roughly how long a person’s life could potentially be extended by this vaccine, if effective, he said “120 years”.
“[The trial] will happen in the UK next year and we expect the drug in the market as soon as possible. I cannot say more because it is confidential,” he said.
I can find lots of references in the 2018 to 2022 time frame, but nothing since then.
I asked Bing Chat for the results of the human trials and it responded with, “I’m sorry, but as of my last update in 2021, I don’t have the most recent information on the results of the human trials for the anti-aging treatment developed by Professor Alessio Lanna and his team at University College London.”
Their web site doesn’t have any information from 2023 either. I suspect things didn’t work out very well.